golidocitinib
Dizal Pharmaceuticals
['golidocitinib', 'lymsm', 'ptcl', 'lymphoma']
#eha2022 | won seog kim, samsung medical center, considers that the initial clinical activity seen in ptcl with golidocitinib, a jak1 inhibitor, is very promising. antibiotic prophylaxis was added after the initial experience with the drug #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm